Results 101 to 110 of about 17,959 (200)
QRS variation –index or percentage– to predict response to cardiac resynchronization therapy?
CorSalud, 2020 QRS variation –index or percentage– to predict response to cardiac resynchronization therapy?
Carlos J. Vásquez Quintero
doaj
Cardiac Resynchronization as an Enabler of ARNI Efficacy: Insights From a Real‐World Cohort
Journal of Arrhythmia, Volume 42, Issue 5, October 2026.CRT provides the mechanical substrate that enables sacubitril/valsartan to maximize reverse remodeling. In this real‐world cohort, ARNI therapy was associated with greater improvement in left ventricular function and fewer clinically validated device‐detected HF events, particularly among CRT responders, supporting a synergistic interaction between ...
Amato Santoro +10 more
wiley +1 more source
Journal of Arrhythmia, Volume 42, Issue 5, October 2026.No significant difference in appropriate ICD therapies between treatment eras. Time to first ICD therapy was similar after propensity‐score matching. The result was robust to a sensitivity analysis using an expanded propensity model. Cumulative incidence, accounting for competing risk of death, was also higher.
Inês Ferreira Neves +11 more
wiley +1 more source
MedComm, Volume 7, Issue 10, October 2026.Postoperative follow‐up for patients with implantable cardioverter‐defibrillators and cardiac resynchronization therapy defibrillators (ICD/CRT‐D) is often delayed in remote areas because of geographic barriers and limited healthcare resources, increasing the risk of adverse outcomes. The “Make Changes” study, was a prospective, multicenter, open‐label
Pan Li +11 more
wiley +1 more source
Artificial Organs, Volume 50, Issue 10, Page 1464-1475, October 2026.This study is a comprehensive post‐market analysis of the Xenios console and XLung kit 230 preconfigured ECMO tubing set in post‐cardiotomy applications. The performance of this device was evaluated and demonstrated in all key clinical areas, with an adequate safety profile.
Luca Conci +9 more
wiley +1 more source
Journal of Cardiovascular Electrophysiology, Volume 37, Issue 10, Page 2409-2412, October 2026.ABSTRACT Background Drug‐refractory ventricular tachycardia (VT) after failed radiofrequency (RF) ablation remains a clinical challenge. Pulsed‐field ablation (PFA) is expanding to ventricular applications, but United States experience with focal pulsed‐field‐only catheters in VT is sparse, and pulsed‐field platforms are not equivalent across ...
Jorge L. Reyes +3 more
wiley +1 more source
Journal of Sleep Research, Volume 35, Issue 5, October 2026.In 15 postoperative cardiac surgery patients, venous reactive oxygen species (ROS) measured by electron spin resonance (ESR) over 48 h showed no consistent circadian pattern. Higher ROS was associated with lower subjective sleep efficiency and more nocturnal awakenings, but not with other sleep measures.
K. Krawczyk +10 more
wiley +1 more source
QT Interval Evaluation in Right Ventricular Pacing: Validation of a Novel Formula
Pacing and Clinical Electrophysiology, Volume 49, Issue 10, Page 1455-1463, October 2026.ABSTRACT Background QT interval measurement in the presence of right ventricular pacing (RVP) represents a clinical challenge. We therefore aimed to derive and validate a formula for QT estimation during RVP in a large cohort of pacemaker patients. Methods and Results We prospectively enrolled 100 patients in a derivation cohort and 487 in a validation
Amr Abdin +9 more
wiley +1 more source
Pacing and Clinical Electrophysiology, Volume 49, Issue 10, Page 1464-1472, October 2026.BiVP = biventricular pacing; CRT = cardiac resynchronization therapy; EMW = electromechanical window; LBBAP = left bundle branch area pacing; QAoC = Time interval from the onset of the QRS complex to the center of the aortic valve closure artifact; QT = QT interval measured by tangent method.
Florien Klein +18 more
wiley +1 more source
Pacing and Clinical Electrophysiology, Volume 49, Issue 10, Page 1595-1603, October 2026.ABSTRACT Background Implantable cardioverter‐defibrillator (ICD) therapy relies on reliable right ventricular leads for pacing, sensing, and defibrillation. The INVICTA DF4 lead is an active‐fixation, quadripolar design intended to optimize implant workflow and long‐term safety and performance. Methods APOLLO was a prospective, multicenter, single‐arm,
Klaus K. Witte +13 more
wiley +1 more source